KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseExpense - Property Taxes and InsuranceExpense - Property and MaintenanceLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherRevenue - Mortgage Backed SecuritiesRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

National Health Investors (NHI) Long-Term Debt Repayments (2016 - 2025)

National Health Investors filings provide 15 years of Long-Term Debt Repayments readings, the most recent being $50.0 million for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments rose 45771.56% to $50.0 million in Q4 2025 year-over-year; TTM through Mar 2026 was $200.7 million, a 166.03% increase, with the full-year FY2025 number at $200.8 million, up 166.21% from a year prior.
  • Long-Term Debt Repayments hit $50.0 million in Q4 2025 for National Health Investors, down from $75.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $220.1 million in Q2 2023 to a low of $98000.0 in Q3 2022.
  • Median Long-Term Debt Repayments over the past 5 years was $50.1 million (2023), compared with a mean of $56.0 million.
  • The widest YoY moves for Long-Term Debt Repayments: up 74261.39% in 2024, down 99.95% in 2024.
  • National Health Investors' Long-Term Debt Repayments stood at $43.0 million in 2021, then crashed by 99.77% to $98000.0 in 2022, then skyrocketed by 51045.92% to $50.1 million in 2023, then crashed by 99.78% to $109000.0 in 2024, then skyrocketed by 45771.56% to $50.0 million in 2025.
  • The last three reported values for Long-Term Debt Repayments were $50.0 million (Q4 2025), $75.0 million (Q3 2025), and $75.7 million (Q2 2025) per Business Quant data.